PSW launches e-certification for pharma exports
Listen to article
In its continued efforts to enhance Pakistan's export competitiveness by digitalizing cross-border trade processes and information requirements, the Pakistan Single Window (PSW), in collaboration with the Drug Regulatory Authority of Pakistan (DRAP), has launched the Digital Certificate of Pharmaceutical Product (COPP), required for the export of pharmaceutical products by importing countries.
In addition to COPP, the DRAP Clearance Gateway has also begun offering electronic Free Sale Certificate, Good Manufacturing Practice (GMP) Certificate, and the No Objection Certificate (NOC) for exports. This initiative aims to streamline regulatory processes, reduce delays, and align Pakistan's pharmaceutical industry with global best practices.
All certificates issued through the PSW platform are secure, electronically verifiable, and embedded with a unique QR code for instant authentication. The service eliminates inefficiencies associated with paper documentation, ensures regulatory compliance, and enhances transparency and trust in Pakistan's pharmaceutical exports, especially in highly regulated markets such as the European Union and the United States.
Exports remain a cornerstone of Pakistan's economic development, and strategic efforts like Uraan Pakistan have been rolled out to support cross-border trade. Among key sectors, the pharmaceutical industry has emerged as a high-potential contributor. In FY 2023-24, Pakistan's pharmaceutical exports reached approximately $341 million, reflecting a 3.90% growth over the previous year.
"We are proud to introduce the Digital Certificate of Pharmaceutical Product, which will bring Pakistan's pharmaceutical industry in line with global best practices," said Aftab Haider, CEO of Pakistan Single Window. "This initiative significantly enhances the efficiency and transparency of our regulatory systems and will boost exports by ensuring our products meet the highest international standards. The initiative is in line with the Prime Minister's vision of a Digital Pakistan."
Dr Obaidullah Malik, CEO of DRAP, emphasised the significance of the development, stating, "The launch of the Digital Certificate of Pharmaceutical Product (COPP), Free Sale Certificate, GMP Certificate, and Export NOC through the DRAP Clearance Gateway reflects our commitment to modernising regulatory practices and strengthening trust in Pakistan's pharmaceutical sector."
This development is a key component of Pakistan's broader strategy to digitalise regulatory systems, improve operational efficiency, and foster export-led growth in the pharmaceutical sector.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
20 hours ago
- Business Recorder
Safer, smarter healthcare services: Federal, Punjab Health ministries to launch joint initiatives
ISLAMABAD: The Federal Health Ministry and the Punjab Health department have decided to join hands for stronger, safer, and smarter healthcare services. The major development for national health collaboration came here on Thursday during a high-level meeting between Federal Minister for Health Mustafa Kamal and Punjab Minister for Primary and Secondary Healthcare Khawaja Imran Nazir. The meeting focused on strengthening coordination between the federal and provincial governments to address critical healthcare challenges and launch joint initiatives across key health areas. The meeting decided taking joint action against counterfeit medicines, coordinated efforts on polio eradication and dengue prevention and advancement of digital health systems and regulatory reform. The meeting was also attended by Special Secretary Health Syed Waqarul Hassan, Additional Secretary Health, Chief Information Officer of DRAP, Director General Health, and the President of the Pakistan Medical and Dental Council (PMDC),Dr Rizwan Taj. Kamal reiterated the federal government's resolve to address healthcare issues with urgency. He stated that under the direction of the prime minister, particular focus is being placed on eliminating polio and ensuring timely implementation of health programmes. 'The fight against polio continues with full zeal, until the virus is eliminated, our children remain at risk,' he emphasised. He shared plans for a new national strategy for polio eradication and urged parents to disregard negative propaganda and ensure their children are vaccinated. 'In Palestine, even during war, mothers call for vaccinators with whistles. Pakistani mothers must also play their part in protecting their children,' he said. Kamal highlighted steps being taken by DRAP to combat counterfeit medicines, including the rollout of a modern barcode system. This will enable every medicine to carry a unique code that patients can scan to verify authenticity and price. Additionally, export certifications such as GMP, CoPP, and NOCs are now being processed online via the Pakistan Single Window, and all regulatory submissions are handled through the new 'e-App' online platform. Provincial Minister Khawaja Imran Nazir reaffirmed Punjab's full support for the federal government's health agenda. 'Punjab has greater capacity and resources, and we are ready to share these to benefit all provinces. The health of our people must come before all else,' he stated. He also praised DRAP's initiatives under the leadership of Minister Kamal, particularly, those targeting counterfeit pharmaceuticals. The two ministers agreed on the importance of coordinated measures to prevent dengue outbreaks in Islamabad and Rawalpindi and committed to united efforts in disease prevention, vaccination campaigns, and health system strengthening. They stressed that collaboration between federal and provincial levels is crucial to achieving meaningful progress in the health sector. Copyright Business Recorder, 2025
Business Recorder
2 days ago
- Business Recorder
‘ST imposition under EFS will sabotage export industry'
FAISALABAD: Addressing at a press conference, Senior Vice Chairman of the Pakistan Hosiery Manufacturers & Exporters Association (PHMA), Hazar Khan, warned that the imposition of sales tax at the import stage under the Export Facilitation Scheme (EFS) will sabotage the export industry. He cautioned that the government's move to impose sales tax at the import stage within the EFS framework would be another severe blow to apparel and textile exporters, who are already under immense financial pressure. He emphasised that the collection and refund process of sales tax is not only inefficient but also provides opportunities for corruption through fake refunds, while genuine exporters face long delays in getting their refunds. The value-added textile sector strongly believes that the EFS should be continued in its original form as it existed prior to Budget 2024-25, to ensure liquidity and transparency in the value chain. This stance is also supported by the inter-ministerial committee, led by the federal minister for Planning, under the directives of the prime minister. Chaudhry Salamat Ali, Group Leader of PHMA, stated that the EFS was developed through consultation with stakeholders and has streamlined, digitised, and improved the efficiency of the export process. Fully automated under WeBOC and PSW systems, the scheme has provided financial relief to exporters. He highlighted that APTMA is using outdated machinery with poor quality and high costs, while value-added garment production requires yarn that meets international standards. The government allowed yarn imports under EFS, which is a key reason for the increase in exports. Arif Ihsan Malik, former Chairman of APBUMA, mentioned that duty-free yarn imports have long been allowed under various SROs, similar to policies followed by Bangladesh, Vietnam, and other countries. He refuted APTMA's claim that 100 of their mills have shut down, calling it baseless and demanding that they share accurate data with the media. He also advocated for allowing commercial importers to bring in yarn under EFS so that small and medium-sized exporters can benefit as well. Mian Kashif Zia, former chairman of PHMA, said that the apparel industries in Bangladesh and Vietnam also rely on imported raw materials and their governments run similar facilitation schemes. Imposing sales tax under EFS would defeat its core purpose. Mian Farrukh Iqbal, former Chairman of PHMA, stated that the government has set a $60 billion export target under the 'Uraan' programme, which will be at risk if the EFS is withdrawn. He further claimed that APTMA produces substandard yarn which fails to meet international expectations, thus compromising the quality of garments made from it. Copyright Business Recorder, 2025
Business Recorder
30-05-2025
- Business Recorder
Spurious, sub-standard drugs: NA body grills DRAP
ISLAMABAD: The National Assembly Standing Committee on National Health Services, Regulations and Coordination (NHSRC), Thursday, grilled the Drug Regulatory Authority Pakistan (DRAP) for ineffective monitoring and failure to control the spread of spurious, unregistered and sub-standard drugs across the country. The committee meeting was held under the chairmanship of Dr Mahesh Kumar Malani, MNA to discuss various pressing issues related to health, licensing of drugs, homeopathic and alternative drugs as well as three amendment bills. The committee disposed-off 'The Pakistan Medical and Dental Council (Amendment) Bill, 2024', moved by Shaista Pervaiz, MNA. Whereas, the debate on 'The Islamabad Healthcare Regulation (Amendment) Bill, 2024', moved by Shaista Pervaiz Malik and 'The Pharmacy (Amendment) Bill, 2024', moved by Abdul Qadir Patel, MNA were deferred due to absence of movers. Discussing the matters pertaining to the working and performance of the DRAP, the committee highlighted the acute shortage of resources, pending recruitments and the need for a robust regulatory framework to address pharmaceutical malpractice. It was recommended that rules for filling vacant positions in DRAP be expedited, alongside efforts to strengthen inspection mechanisms for pharmaceutical products and vaccines. Members also stressed the importance of harmonising drug licensing procedures to reduce delays and ensure the availability of quality-assured medicines. The committee urged DRAP to adopt a more proactive approach in monitoring drug efficacy, availability and pricing to safeguard public health interests. The committee members also recommended enhancing the existing penalties for non-compliance of standards. Additionally, the need to prioritize local manufacturing of essential vaccines was emphasised to minimise reliance on imports and ensure a steady supply. The committee commended DRAP for its efforts to digitize the drug licensing application process. It was noted that a standardised harmonised form has been developed to streamline licensing procedures. The committee emphasised the importance of establishing clear and stringent rules for drug licensing to enhance transparency and efficiency. Additionally, the committee directed DRAP to share the finalised licensing rules in the next meeting. Briefing the panel, Dr Obaidullah, chief executive officer (CEO) DRAP said that the organisation was facing serious shortage of staff not only at senior level but junior level, adding that monitoring and controlling of spurious, substandard and unregistered drugs was not only DRAP's responsibility but largely provincial governments' were responsible for it as health after 18th constitutional amendment was a devolved subject. He said that the DRAP was making all possible efforts to ensure effective regulation across the board and to deal with the staff shortage board has sent a summary to the federal government. The committee discussed several issues such as the regulation of food standards, healthcare governance and recruitment practices. The committee members expressed concerns over the Ministry of Science and Technology's delay in addressing unresolved matters related to food product standards, particularly the introduction of front-of-package warnings. Recognising the adverse health impacts of ultra-processed foods, the committee recommended imposing a levy on such products. The revenue generated would support health promotion initiatives aimed at combating non-communicable diseases. The issue of administrative inefficiencies and recruitment delays at institutions such as Polyclinic and the Islamabad Healthcare Regulatory Authority (IHRA) was also discussed in depth. Members urged immediate action to ensure transparency and fairness in hiring practices. The committee directed the ministry to submit detailed reports on recruitment processes and measures to enhance institutional accountability in the next meeting. The meeting was attended by MNAs, Dr Shazia Sobia Aslam Soomro, Sabheen Ghoury, Farah Naz Akbar, Dr Nikhat Shakeel Khan, Aliya Kamran, Zahra Wadood Fatemi, Shahram Khan, Dr Amjad Ali Khan, Shabbir Ali Qureshi, Azimud Din Zahid Lakhwi in person, whereas, Nisar Ahmed, MNA attended virtually. The minister for NHSR&C, the secretary along with senior officers from the ministry and its attached departments attended the meeting. Copyright Business Recorder, 2025
